FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096436020> ?p ?o ?g. }

• W3096436020 endingPage "40" @default.
• W3096436020 startingPage "39" @default.
• W3096436020 abstract "Introduction Iron deficiency anemia (IDA) is the most common cause of anemia in both developed and developing countries, particularly affecting females in the child bearing age and children. The treatment of IDA is a major health goal, it consists of treating the underlying cause and iron supplements. Iron replacement comes in form of oral or intravenous, there are certain side effects of this therapy including constipation and allergy. Leukopenia as a side effect of iron therapy is under reported in the literature as only sporadic cases were prescribed. We conducted a study to clarify this issue and to check for its clinical significance. Objective: To assess the relationship between iron therapy (intravenous) and leukopenia, neutropenia or lymphocytopenia, and its impact on patient's clinical settings. Materials and Methods We retrospectively reviewed the electronic medical records of patients attended Haematology clinic for iron deficiency anemia and treated with intravenous iron (ferric carboxymaltose or iron saccharide) over 2 years in Hamad Medical Corporation, Doha/Qatar. Adult female patients with IDA cases who received IV iron were included. anemia due to other nutrients deficienciesa nd conditions (including other medications) that may alter WBCs count were excluded.Age, Ethnicity, BMI, Complete blood count and iron studies data were collected before and after treatment with IV iron therapy. Infection occurrence at the time of IDA and leukopenia, the use of antibiotics and infection related complications were also collected. Leukopenia was defined as WBCs count to be less than 4000/microlitre, Neutropenia as ANC less than 1500/microlitre and lymphocytopenia as lymphocytes less than 1000/mocrolitre. Statistical analysis was done using mean , SD and t test. Results After iron therapy, out of 1567 case of iron deficiency anemia, 30 cases (1.914%) have leukopenia,15 cases (0.957%) have neutropenia and 12 cases (0.765%) have lymphocytopenia. All had normal readings before treatment. 2 patients (6.66%) had infection, 1 had upper respiratory tract infection and 1 urinary tract infection, the latter was treated with antibiotics, none reported infection related complications Discussion Leukocytopenia is defined as low WBCs circulating in the blood and this can be caused by low neutrophils count, low lymphocytes count, other WBCs components or combined. Some previous reported cases generated the idea of a possible connection between iron supplement therapy and leukopenia, Brito-Babapulle et al reported a case of fatal bone marrow suppression linked to ferric carboxymaltose therapy in a patient with IDA. The pathophysiology is not well understood but thought to be a toxic effect of iron on bone marrow and it can affect all cell lineages. Our findings suggest possible iron replacement side effect as there was significant drop of the WBCs count after treating IDA patients with IV iron, however this association was not common. There was no life threatening or serious infections in the affected patients, which can suggest that most of these cases are mild and transient. More studies are needed to address this issue, particularly on larger scales. Patient education also may be appreciated before treatment with IV iron. Conclusions: Leukopenia in form of neutropenia or lymphocytopenia maybe a side effect of IV iron therapy. Clinical significance is limited in view of current literature further studies needed to elaborate more in this important adverse event. Disclosures No relevant conflicts of interest to declare." @default.
• W3096436020 created "2020-11-09" @default.
• W3096436020 creator A5005070683 @default.
• W3096436020 creator A5006327243 @default.
• W3096436020 creator A5011561534 @default.
• W3096436020 creator A5044845842 @default.
• W3096436020 creator A5054398225 @default.
• W3096436020 creator A5058357950 @default.
• W3096436020 creator A5062475968 @default.
• W3096436020 creator A5067200214 @default.
• W3096436020 creator A5067909941 @default.
• W3096436020 creator A5077889635 @default.
• W3096436020 creator A5084206162 @default.
• W3096436020 creator A5090171300 @default.
• W3096436020 creator A5091308540 @default.
• W3096436020 date "2020-11-05" @default.
• W3096436020 modified "2023-10-16" @default.
• W3096436020 title "Iron Therapy Induced Leukopenia" @default.
• W3096436020 doi "https://doi.org/10.1182/blood-2020-135951" @default.
• W3096436020 hasPublicationYear "2020" @default.
• W3096436020 type Work @default.
• W3096436020 sameAs 3096436020 @default.
• W3096436020 citedByCount "0" @default.
• W3096436020 crossrefType "journal-article" @default.
• W3096436020 hasAuthorship W3096436020A5005070683 @default.
• W3096436020 hasAuthorship W3096436020A5006327243 @default.
• W3096436020 hasAuthorship W3096436020A5011561534 @default.
• W3096436020 hasAuthorship W3096436020A5044845842 @default.
• W3096436020 hasAuthorship W3096436020A5054398225 @default.
• W3096436020 hasAuthorship W3096436020A5058357950 @default.
• W3096436020 hasAuthorship W3096436020A5062475968 @default.
• W3096436020 hasAuthorship W3096436020A5067200214 @default.
• W3096436020 hasAuthorship W3096436020A5067909941 @default.
• W3096436020 hasAuthorship W3096436020A5077889635 @default.
• W3096436020 hasAuthorship W3096436020A5084206162 @default.
• W3096436020 hasAuthorship W3096436020A5090171300 @default.
• W3096436020 hasAuthorship W3096436020A5091308540 @default.
• W3096436020 hasConcept C126322002 @default.
• W3096436020 hasConcept C141071460 @default.
• W3096436020 hasConcept C187212893 @default.
• W3096436020 hasConcept C2776694085 @default.
• W3096436020 hasConcept C2777063308 @default.
• W3096436020 hasConcept C2777417653 @default.
• W3096436020 hasConcept C2777761686 @default.
• W3096436020 hasConcept C2777990475 @default.
• W3096436020 hasConcept C2778248108 @default.
• W3096436020 hasConcept C2779788118 @default.
• W3096436020 hasConcept C2780873365 @default.
• W3096436020 hasConcept C71924100 @default.
• W3096436020 hasConcept C89560881 @default.
• W3096436020 hasConceptScore W3096436020C126322002 @default.
• W3096436020 hasConceptScore W3096436020C141071460 @default.
• W3096436020 hasConceptScore W3096436020C187212893 @default.
• W3096436020 hasConceptScore W3096436020C2776694085 @default.
• W3096436020 hasConceptScore W3096436020C2777063308 @default.
• W3096436020 hasConceptScore W3096436020C2777417653 @default.
• W3096436020 hasConceptScore W3096436020C2777761686 @default.
• W3096436020 hasConceptScore W3096436020C2777990475 @default.
• W3096436020 hasConceptScore W3096436020C2778248108 @default.
• W3096436020 hasConceptScore W3096436020C2779788118 @default.
• W3096436020 hasConceptScore W3096436020C2780873365 @default.
• W3096436020 hasConceptScore W3096436020C71924100 @default.
• W3096436020 hasConceptScore W3096436020C89560881 @default.
• W3096436020 hasIssue "Supplement 1" @default.
• W3096436020 hasLocation W30964360201 @default.
• W3096436020 hasOpenAccess W3096436020 @default.
• W3096436020 hasPrimaryLocation W30964360201 @default.
• W3096436020 hasRelatedWork W1994300152 @default.
• W3096436020 hasRelatedWork W202103840 @default.
• W3096436020 hasRelatedWork W2112821742 @default.
• W3096436020 hasRelatedWork W3037557039 @default.
• W3096436020 hasRelatedWork W3096436020 @default.
• W3096436020 hasRelatedWork W3097710875 @default.
• W3096436020 hasRelatedWork W3177286276 @default.
• W3096436020 hasRelatedWork W3181000026 @default.
• W3096436020 hasRelatedWork W4280652309 @default.
• W3096436020 hasRelatedWork W4283783635 @default.
• W3096436020 hasVolume "136" @default.
• W3096436020 isParatext "false" @default.
• W3096436020 isRetracted "false" @default.
• W3096436020 magId "3096436020" @default.
• W3096436020 workType "article" @default.